Abstract
Emphysematous pyelonephritis (EPN) is a rare condition which is potentially life threatening. It is characterised by gas formation within the collecting system, renal parenchyma and/or perirenal tissues. Diabetes is the single most common risk factor for the development of EPN. Other risk factors include urinary tract obstruction and immunocompromise. Escherichia Coli is the most common pathogen. EPN is characterised by fever, loin pain and systemic upset. Gold standard diagnosis and classification of EPN is made with contrast CT. Classification can be used as a prognostic indicator for mortality and to guide management. EPN may be managed conservatively or surgically. Patients managed conservatively are resuscitated and administered with intravenous antibiotics. Intravenous fluid, glucose control for diabetics and acid base balance are vital components for primary management. For those in whom conservative management is unsuccessful, a parenchymal drain may be considered to drain gas or a collection of pus. Patients with hydronephrosis will benefit from a nephrostomy or JJ stent insertion. Patients who have failed minimally invasive surgical intervention or who have a number of risk factors predisposing them to EPN should undergo either immediate or delayed nephrectomy. With treatment for EPN now moving away from nephrectomy towards less invasive interventions, mortality rates for EPN are improving but remaining high.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001;34(2):125–30.
Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797–805.
Wan YL, LeeTY BMJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996;198:433–8.
Somani BK, Nabi G, Thorpe P, et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008;179:1844–9.
Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009;6:272–9.
Behera V, Vasantha Kumar RS, Mendonca S, Prabhat P, Naithani N, Nair V. Emphysematous infections of the kidney and urinary tract: a single-center experience. Saudi J Kidney Dis Transpl. 2014;25(4):823–9.
Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis. 2014;14:418. A valuable article as it ascertains predictors of failure with conservative management, thereby helping practitioners to identify the cohort of patients who would benefit from early percutaneous drainage.
Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int. 2011;107(9):1474–8.
Arsene C, Saste A, Arul S, Mestrovich J, Kammo R, Elbashir M, et al. A case series of emphysematous pyelonephritis. Case Rep Med. 2014;2014:587926.
Kim MJ, Park JS, Lim HJ, Jung J, Shin DG, Lee KD, et al. Emphysematous pyelonephritis caused by citrobacter freundii in a patient with type 2 diabetes and neurogenic bladder. Infect Chemother. 2013;45(3):331–4.
Bhat RA, Bashir G, Wani M, Lone S. Emphysematous pyelonephritis caused by Candida parapsilosis: an unknown etiological agent. N Am J Med Sci. 2012;4(8):364–6.
Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A. Imaging features and guided drainage in emphysematous pyelonephritis: a study of 11 cases. Clin Radiol. 2004;59:192–7.
Das CJ, Ahmad Z, Sharma S, Gupta AK. Multimodality imaging of renal inflammatory lesions. World J Radiol. 2014;6(11):865–73.
Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol. 1984;131(2):203–8.
Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998;159(2):369–73.
Falagas ME, Alexiou VG, Giannopoulou KP, Seimpos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007;178(3 pt 1):880–5.
Aswathaman K, Gopalakrishnan G, Gnanaraj L, Chacko NK, Kekre NS, Devasia A. Emphysematous pyelonephritis: outcome of conservative management. Urology. 2008;71(6):1007–9.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and shock. N Engl J Med. 2001;345(19):1367–77.
Mallet M, Knockaert DC, Oyen RH, Van Poppel HP. Emphysematous pyelonephritis: no longer a surgical disease? Eur J Emerg Med. 2002;9(3):266–9.
Nanki T, Ageishi Y, Iwama T, Murase H, Uchikawa T. Emphysematous pyelonephritis successfully treated with nephrectomy and granulocyte colony-stimulating factor. Intern Med. 1994;33(4):234–6.
Cheng YT, Wang HP, Hsieh HH. Emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and nephrostomy. Clin Transplant. 2001;15(5):374–7.
Dellinger RP, Levy MM, Rhodes A, Annanne D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. Emphysematous Pyelonephritis often presents with sepsis. Early and appropriate management of sepsis is vital if mortality is to be avoided. Since the introduction of the surviving sepsis campaign, we have seen a 25 % improvement in mortality outcomes in sepsis.
Sharma PK, Sharma R, Vijay MK, Tiwari P, Goel A, Kundu AK. Emphysematous Pyelonephritis: our experience with conservative management in 14 cases. Urol Ann. 2013;5(3):157–62.
Laway BA, Bhat MA, Bashir MI, Ganie MA, Mir SA, Daga RA. Conservative management of emphysematous pyelonephritis. Indian J Endocrinol Metab. 2012;16(2):303–5.
Bhat RA, Khan I, Khan I, Palla N, Mir T. Emphysematous Pyelonephritis: outcome with conservative management. Indian J Nephrol. 2013;23(6):444–7. This paper identified risk factors that can be used to identify patients with a poorer prognosis and uses to this identify patients in whom conservative management should not be attempted.
Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009;6(5):272–9.
Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC. Percutaneous drainage in treatment of emphysematous pyelonephritis: 10-year experience. J Urol. 1997;157(5):1569–73.
Matsuura H, Kanai M, Tochigi H. A case of emphysematous pyelonephritis successfully treated with multiple CT guided percutaneous drainage procedures. Hinyokika Kiyo. 2013;59(8):527–30.
Akpek S, Turgut T, Ozdemir H, Ilgit ET, Işik S. Emphysematous pyelonephritis: fatal outcome during percutaneous drainage. Eur J Radiol. 1998;26(3):287–9.
Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986–9.
Dhabalia JV, Nelivigi GG, Kumar V, Gokhale A, Punia MS, Pujari N. Emphysematous pyelonephritis: tertiary care centre experience in management and review of the literature. Urol Int. 2010;85(3):304–8.
Pontin AR, Barnes RD, Joffe J, Kahn D. Emphysematous pyelonephritis in diabetic patients. Br J Urol. 1995;75:71–4.
Compliance with Ethics Guidelines
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Inflammatory/Infectious Bladder Disorders
Rights and permissions
About this article
Cite this article
Mahesan, T., Reddy, U.D., Chetwood, A. et al. Emphysematous Pyelonephritis: a Review of a Rare Condition. Curr Bladder Dysfunct Rep 10, 207–211 (2015). https://doi.org/10.1007/s11884-015-0303-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-015-0303-x